Where does Berry Genomics Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Berry Genomics Co., Ltd. ranks #34,451 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Berry Genomics Co., Ltd. hold?

Berry Genomics Co., Ltd. holds 7 US utility patents granted between 2017 and 2024, spanning 5 technology areas.

What is Berry Genomics Co., Ltd.'s Innovation Score?

Berry Genomics Co., Ltd. has an Innovation Score of 31.0 out of 100 (36th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Berry Genomics Co., Ltd.'s patent grant rate increasing or decreasing?

Berry Genomics Co., Ltd.'s recent grant velocity is +33% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Berry Genomics Co., Ltd.'s patents?

Berry Genomics Co., Ltd.'s patents average 9.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Berry Genomics Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Berry Genomics Co., Ltd.

Q: What technology areas does Berry Genomics Co., Ltd. focus on?

Berry Genomics Co., Ltd.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 7 patents, ranking #618 of 2,502 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 5 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Berry ranks #34,451 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 5 technology areas.

#34,451
of 49,997 US assignees by volume: 36th percentile
by Innovation Score (31.0/100): 9.9
avg claims per patent: +33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R34451 · Foreign Corporation #34,451 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #34,451/49,997
PHOTO-FINISH Beijing Tonglanhai…
CPC-NARROW C12Q · 5 areas
INNOV-THIN 31.0/100
CLAIMS-PAR 9.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Beijing Tonglanhai Technology Co., Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Berry’s 31.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (23%) Velocity 10.0 pts (32%) Breadth 7.9 pts (25%) Claim depth 5.9 pts (19%)

Qualcomm Incorporated · highest

85
Berry Genomics · this assignee

31
3D Lighting… · lowest

7

What this shows Berry's Innovation Score is 31.0/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Berry?

Each dot is one of Berry’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Berry’s own 9.9 claims/patent is ABOVE the 6.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Berry vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Berry's grants concentrate

Berry Genomics Co., Ltd. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2017. By volume, Berry sits between Beijing Tonglanhai Technology Co., Ltd and Bestore Europe Holding GMBH.

Berry's three-year grant acceleration

Berry Genomics Co., Ltd. shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Beijing Tonglanha…

7
Beit

7
Bekaert Combustio…

7
Berk-tek

7
Besst

7
Best Friend Group…

7
Bestline Internat…

7
Bestore Europe Ho…

7
Berry Genomics ◀

7

What this shows Berry holds 7 patents at rank #34,420, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Berry

By rank, the assignees closest to #34,420 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Berry's primary technology class.

Berry's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 36th percentile higher than 36% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Berry Genomics Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	14.3%
2018	1	14.3%
2019	1	14.3%
2020	1	14.3%
2022	1	14.3%
2024	2	28.6%

Which technologies does Berry Genomics Co., Ltd. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 2

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

C07K - Peptides 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Berry Genomics Co., Ltd.'s patent record in context - here's where to go next.

Berry Genomics Co., Ltd.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 100% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #34,451 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Berry Genomics Co., Ltd. against Beijing Tonglanhai Technology Co., Ltd, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.